These emerging medications , including Semaglutide , Mounjaro , and Zaxig , represent a significant advancement in treating type 2 the condition and supporting weight management. They function by imitating the body’s natural incretin signal , enabling to regulate blood levels and decrease hunger . Each drug has slightly unique characteristics and